<?xml version="1.0" encoding="UTF-8"?>
<p id="JVEv5-para-0064">The challenges in terms of biomarkers to monitor HIV-1 cure are comparable to those in HBV cure research where cccDNA is relatively inaccessible to sampling and the surface antigen (HBVsAg) expression does not confirm the presence of replication-competent virus. Researchers in both fields take into account that a reliable biomarker for cure will need to reflect true disease remission in tissue and not only in blood.</p>
